1. From the Department of Neurology (W.-R.S.), University of Münster, Germany; the Department of Neurology (T.S., S.S.), University of Erlangen, Germany; the Department of Neuropathology (C.S.), University of Mainz, Germany; Sygnis Pharma (A.S.), Heidelberg, Germany; and the Institute for Neuroscience and Physiology (C.M.C.-K., H.G.K.), Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.